Back to Top Skip to main content Skip to sub-navigation

Searching for clues under the microscope to understand COVID-19

Researcher placing a drop of fluid under a microscope. Pathologists at the Joint Pathology Center are searching for clues to understand how COVID-19 is harming patients. (U.S. Air Force photo by Staff Sgt. Matthew J. Wisher)

Recommended Content:

Coronavirus

Pathologists at the Joint Pathology Center meticulously piece together clues to help health care providers better understand COVID-19. By studying tissue samples under the microscope, patterns emerge of the damage that the respiratory virus leaves in the human body, said Army Col. (Dr.) Joel Moncur, director of the JPC. The center consults with medical facilities in New York City on adult and pediatric cases of COVID-19 to help further unravel the mysterious effects of the disease.

Nestled within the Defense Health Agency, the JPC serves as the reference pathology lab for the entire Military Health System, the Department of Veteran’s Affairs, and the federal government on the most challenging cases, according to Moncur. By serving as a centralized review site, the pathologists at JPC compare findings across multiple patients and compile data in order to track disease trends that may affect the fighting force, he added.

With 19 subspecialties, JPC’s pathologists provide expertise in all the major organs of the body, including the lungs. “By looking through a microscope at tissues, we can learn if a disease is related to inflammation or if it’s cancerous and, if it is cancer, if it is slow growing or highly aggressive,” explained Moncur.

COVID-19, a type of coronavirus, ravages the human body in new and unprecedented ways—from causing blood clots and lung damage to creating dangerous immune responses in adults and children, according to Moncur. “Pathology has an enormous amount to contribute because if we can understand the disease, then it’s possible to suggest logical treatments and potential methods of prevention,” he said.

JPC’s long history provides many examples of pathologists playing a key role in changing the way the medical and scientific communities view disease. “In fact, many of the pathologists at the JPC have made discoveries that are now part of the official classifications of diseases as a result of their thoughtful observations,” he said, adding that an average of 70% of medical decisions for any patient result from laboratory testing and analysis.

Like detectives, pathologists search for evidence within tissue samples, but those at JPC also use the lab’s rich historical data to help tell the story of a disease or outbreak. The center maintains the world’s largest collection of preserved human tissue samples, going back to 1917, said Moncur. An official audit in 2006 found over 55 million glass slides and at least 35 million tissue block samples. These samples span every major epidemic and pandemic in the past century, including the 1918 Spanish flu pandemic. In fact, according to Moncur, in 1997 a scientist using tissue from the JPC repository published research stating that a novel H1N1 influenza virus served as the source of the so-called Spanish flu, which killed over 50 million people, and that a bacterial pneumonia acted as a common secondary cause of death. “It was really significant information because it changed the face of public health from that point forward,” he added, noting public health scientists have used information from that research to help prevent future outbreaks.

Working in collaboration with civilian medical facilities in New York City, JPC pathologists scour for clues to understand COVID-19. JPC pathologists also work with researchers at the U.S. Army Medical Research Institute of Infectious Disease, the Uniformed Services University of Health Sciences, and the National Institutes of Health to analyze and study how COVID-19 causes damage within the body.

The JPC is part of the DHA's National Capital Region Market. Markets are groups of military treatment facilities in specific regions of the United States that operate as a system, sharing patients, staff, administrative functions and budgets across facilities to improve coordination in the delivery of military health care.

“By examining the tissues, we hope to understand how COVID-19 is harming patients and understand the second and third order of effects of that infection, just like with the 1918 flu,” said Moncur. “That information can point to possible treatments that could be investigated.”

You also may be interested in...

DHA-PI 6205.01: Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

This Defense Health Agency-Procedural Instruction (DHA-PI), based on the authority of References (a) and (b), and in accordance with the guidance of References (c) through (n), establishes the Defense Health Agency's (DHA's) procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits.

DHA-IPM 20-004: Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

This Defense Health Agency (DHA) Interim Procedures Memorandum (IPM), based on the authority of References (a) through (d), and in accordance with the guidance cited in References (e) through (aa), establishes the DHA’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the COVID-19 Vaccination Program. This DHA-IPM applies to DHA, DHA Components (activities under the authority direction, and control of the DHA), Military Departments (MILDEP), and the United States Coast Guard (CG). This DHA-IPM cancels and replaces DHA-IPM 20-004, “Department of Defense (DoD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation,” December 13, 2020.

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: Coronavirus

Supplemental Guidance for Providing DoD Coronavirus Disease 2019 Vaccines to DoD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components as appropriate.

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DoD beneficiaries treated at military medical treatment facilities.

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DoD Component for executing this guidance, in coordination with the Military Departments and other DoD Components.

DHA-AI 3020-01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), based on the authority of References (a) through (b) and in accordance with the guidance of References (c) through (z3), establishes the Defense Health Agency's (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic. This DHA-AI also provides a preventive plan to monitor and assess for the appearance of new cases and implement those processes that will prevent them from impacting the workforce. The processes describe herein are intended to offer an actionable plan for the workforce to re-enter DHA Administrative Offices. See Appendix 1 for a summary of the DHA Administrative Office Reopening Plan. The plan uses the Force Health Protection Guidance and Health Protection Conditions (HPCON), in accordance with Reference (d), to ensure protection for the workforce, including the most vulnerable-to-serious complications from the virus while enabling DHA Administrative Offices to continue its mission. See Appendix 2 for the conceptual HPCON framework.

  • Identification #: 3020-01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus

DHA AI 3020.01: Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 (COVID-19) Environment

Policy

This Defense Health Agency-Administrative Instruction (DHA-AI), establishes the Defense Health Agency’s (DHA) plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic and in preparation for regression or resurgence in COVID-19 cases that could impact the workforce.

  • Identification #: DHA AI 3020.01
  • Date: 6/12/2020
  • Type: Administrative Instructions
  • Topics: Coronavirus
Showing results 1 - 10 Page 1 of 1

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.